6-mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular block
DC CAFCFirst Claim
Patent Images
1. A 6-mercapto-cyclodextrin derivative having the general formula I
2 Assignments
Litigations
0 Petitions
Accused Products
Abstract
Disclosed is a 6-mercapto-cyclodextrin derivative having general formula (I) wherein m is 0-7 and n is 1-8 and m+n=7 or 8; R is (C1-6)alkylene, optionally substituated with 1-3 OH groups, or (CH2)o-phenylene-(CH2)p—; o and p are independently 0-4; X is COOH, CONHR1, NHCOR2, SO2OH, PO(OH)2, O(CH2—CH2—O)q—H, OH or tetrazol-5-yl; R1 is H or (C1-3)alkyl; R2 is carboxyphenyl; q is 1-3; or pharmaceutically acceptable salts thereof. The 6-mercaptocyclodextrin derivative is highly suitable for use in the reversal of drug-induced neuromuscular block.
26 Citations
21 Claims
- 1. A 6-mercapto-cyclodextrin derivative having the general formula I
-
5. A pharmaceutical composition comprising a 6-mercapto-cyclodextrin derivative having the general formula I
- 6. A kit for providing neuromuscular block and its reversal comprising (a) a neuromuscular blocking agent, and (b) a 6-mercapto-cyclodextrin derivative according to the general formula I
-
9. A method for reversal of drug-induced neuromuscular block in a patient, which comprises parenterally administering to said patient an effective amount of a 6-mercaptocyclodextrin derivative according to the general formula I
-
11. 6-Per-deoxy-6-per-(2-carboxyethyl)thio-γ
- -cyclodextrin, or a pharmaceutically acceptable salt thereof.
-
12. 6-Per-deoxy-6-per-(2-carboxyethyl)thio-γ
- -cyclodextrin, sodium salt.
-
13. A pharmaceutical composition comprising 6-per-deoxy-6-per-(2-carboxyethyl)thio-γ
- -cyclodextrin, or a pharmaceutically acceptable salt thereof, and a pharmaceutically suitable auxiliary.
-
14. A pharmaceutical composition comprising 6-per-deoxy-6-per-(2-carboxyethyl)thio-γ
- -cyclodextrin, sodium salt, and a pharmaceutically suitable auxiliary.
-
15. A kit for providing neuromuscular block and its reversal comprising (a) a neuromuscular blocking agent, and (b) 6-per-deoxy-6-per-(2-carboxyethyl)thio-γ
- -cyclodextrin, or a pharmaceutically acceptable salt thereof.
- View Dependent Claims (17, 18, 19)
-
16. A kit for providing neuromuscular block and its reversal comprising (a) a neuromuscular blocking agent, and (b) 6-per-deoxy-6-per-(2-carboxyethyl)thio-γ
- -cyclodextrin, sodium salt.
-
20. A method for reversal of drug-induced neuromuscular block in a subject, which comprises parenterally administering to said subject an effective amount of 6-per-deoxy-6-per-(2-carboxyethyl)thio-γ
- -cyclodextrin, or a pharmaceutically acceptable salt thereof.
-
21. A method for reversal of drug-induced neuromuscular block in a subject, which comprises parenterally administering to said subject an effective amount of 6-per-deoxy-6-per-(2-carboxyethyl)thio-γ
- -cyclodextrin, sodium salt.
Specification